Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: A double-blind randomized placebo controlled clinical trial

Synbiotics and probiotics in the critically ill after the PROPATRIA trial

(2012) Lee E. Morrow et al.   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE

Antibiotic Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

(2011) Khurram J Khan et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Comparative genomics of Escherichia coli isolated from patients with inflammatory bowel disease

(2011) Rebecca Munk Vejborg et al.   BMC GENOMICS

Treatment of Inflammatory Bowel Disease Associated E. coli with Ciprofloxacin and E. coli Nissle in the Streptomycin-Treated Mouse Intestine

(2011) Andreas Munk Petersen et al.   PLoS One

Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN)

(2010) Harald Matthes et al.   BMC Complementary and Alternative Medicine

Sever Sepsis After Probiotic Treatment With Escherichia coli NISSLE 1917

(2010) Katrin Guenther et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

A phylogenetic group of Escherichia coli associated with active left-sided Inflammatory Bowel Disease

(2009) Andreas M Petersen et al.   BMC MICROBIOLOGY

Precolonized Human Commensal Escherichia coli Strains Serve as a Barrier to E. coli O157:H7 Growth in the Streptomycin-Treated Mouse Intestine

(2009) M. P. Leatham et al.   INFECTION AND IMMUNITY

Survival of the probiotic Escherichia coli Nissle 1917 (EcN) in the gastrointestinal tract given in combination with oral mesalamine to healthy volunteers

(2009) Thai Hoa Joeres-Nguyen-Xuan et al.   INFLAMMATORY BOWEL DISEASES

Probiotic Escherichia coli Nissle 1917 (EcN) for Successful Remission Maintenance of Ulcerative Colitis in Children and Adolescents: an Open-Label Pilot Study 

(2008) J Henker et al.   ZEITSCHRIFT FUR GASTROENTEROLOGIE